Date	Headline
Aug 05, 2019	Aytu BioScience Announces First ZolpiMist(TM) Clinical Study Results Demonstrating More Rapid Sleep Onset with Lingual Spray Zolpidem versus Oral Tablet
Aug 01, 2019	Natesto Spermatogenesis Study Final Results Accepted for Presentation at 'Late-Breaking' Session at the American Society for Reproductive Medicine 75th Annual Scientific Conference
Jul 30, 2019	Aytu BioScience Expands Natesto(R) Partnership with Acerus Pharmaceuticals to Accelerate Natesto Growth in the U.S.
Jul 24, 2019	Natesto(R) Added to National Pharmacy Benefit Manager's Formulary Natesto Now Covered on Payer Plans Covering Over 6 Million U.S. Lives
Jul 08, 2019	Aytu BioScience Announces Publication of Clinical Study Results Demonstrating Effectiveness of Natesto(R) Regardless of Patients’ Baseline Hypogonadism Severity

Hayden IR

James Carbonara
1441 Broadway
Fifth Floor
New York, NY 10018
Office: (646)-755-7412
James@haydenir.com

Filing Date	Form Type	Description	View
May 14, 2019	10-Q	Quarterly report	html pdf xbrl
May 14, 2019	10-Q/A	Quarterly report (Amendment)	html pdf xbrl
Feb 07, 2019	10-Q	Quarterly report	html pdf xbrl
Nov 07, 2018	10-Q	Quarterly report	html pdf xbrl
Sep 06, 2018	10-K	Annual report	html pdf xbrl

Financial Tearsheet